Cargando…
ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer
Targetable drivers governing 5-fluorouracil and cisplatin (5FU + CDDP) resistance remain elusive due to the paucity of physiologically and therapeutically relevant models. Here, we establish 5FU + CDDP resistant intestinal subtype GC patient-derived organoid lines. JAK/STAT signaling and its downstr...
Autores principales: | Wong, Tin-Lok, Loh, Jia-Jian, Lu, Shixun, Yan, Helen H. N., Siu, Hoi Cheong, Xi, Ren, Chan, Dessy, Kam, Max J. F., Zhou, Lei, Tong, Man, Copland, John A., Chen, Leilei, Yun, Jing-Ping, Leung, Suet Yi, Ma, Stephanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199093/ https://www.ncbi.nlm.nih.gov/pubmed/37208334 http://dx.doi.org/10.1038/s41467-023-38581-8 |
Ejemplares similares
-
The ADAR1 editome reveals drivers of editing-specificity for ADAR1-isoforms
por: Kleinova, Renata, et al.
Publicado: (2023) -
ADAR1 Editing and its Role in Cancer
por: Xu, Li-Di, et al.
Publicado: (2018) -
RNA Editing, ADAR1, and the Innate Immune Response
por: Wang, Qingde, et al.
Publicado: (2017) -
Modulation of ADAR1 editing activity by Z-RNA in vitro
por: Koeris, Michael, et al.
Publicado: (2005) -
ADAR1-Mediated RNA Editing and Its Role in Cancer
por: Liu, Jizhe, et al.
Publicado: (2022)